This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kariagina, A. Articles by Haslam, S. Z. Search for Related Content PubMed PubMed Citation Articles by Kariagina, A. Articles by Haslam, S. Z.

Progesterone Receptor Isoforms and Proliferation in the Rat Mammary Gland during Development

Breast Cancer and the Environment Research Center, Department of Physiology (A.K., S.Z.H.) and Cell and Molecular Biology Program (M.D.A.), Michigan State University, East Lansing, Michigan 48824

Address all correspondence and requests for reprints to: Sandra Z. Haslam, Ph.D., Department of Physiology, 2201 Biomedical and Physical Sciences Building, Michigan State University, East Lansing, Michigan 48824. E-mail: shaslam{at}msu.edu.

Progesterone (P), acting through progesterone receptor (PR) isoforms A and B, plays an important role in normal mammary gland development and is implicated in the etiology of breast cancer. Because of significant similarities between human and rat mammary gland development and hormonal responsiveness of mammary cancers, we investigated P action in the rat mammary gland. By immunohistochemical methods we determined PRA and PRB expression at puberty, sexual maturity, pregnancy, and lactation and after postlactational involution and their functional roles in the regulation of proliferation. PRA expression was restricted to luminal epithelial cells, whereas PRB was expressed in both luminal and myoepithelial cells, indicating a novel role of PRB in myoepithelial cell regulation. The majority of PRA-positive (PRA+) cells coexpressed PRB. In the pubertal and adult virgin mammary gland, PRA+PRB+ cells also expressed nuclear cyclin D1 but did not contain the proliferation marker bromodeoxyuridine. Based on a lack of phosphorylated retinoblastoma protein expression and the expression patterns of the cyclin-dependent kinase inhibitors p21 and p27 in these cells, we conclude that PRA+PRB+ cells appear to be cell cycle arrested and do not proliferate. PRA+ cells were decreased in the adult gland and during and after pregnancy. The percentage of PRB+ cells was relatively constant throughout development, and in a significant proportion of cells, only PRB was detected. During development, and especially during pregnancy, a high percentage of PRB+ cells were positive for bromodeoxyuridine. From this observation, we conclude that these cells proliferate and that P acting through PRB may directly stimulate proliferation.

This article has been cited by other articles:

				M. A. Behera, Q. Dai, R. Garde, C. Saner, E. Jungheim, and T. M. Price Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1089 - E1096. [Abstract] [Full Text] [PDF]

				M. E. Wlodek, V. Ceranic, R. O'Dowd, K. T. Westcott, and A. L. Siebel Maternal Progesterone Treatment Rescues the Mammary Impairment Following Uteroplacental Insufficiency and Improves Postnatal Pup Growth in the Rat Reproductive Sciences, April 1, 2009; 16(4): 380 - 390. [Abstract] [PDF]

				S. J. Santos, S. Z. Haslam, and S. E. Conrad Estrogen and Progesterone are Critical Regulators of Stat5a Expression in the Mouse Mammary Gland Endocrinology, January 1, 2008; 149(1): 329 - 338. [Abstract] [Full Text] [PDF]

				K. Britt, A. Ashworth, and M. Smalley Pregnancy and the risk of breast cancer Endocr. Relat. Cancer, December 1, 2007; 14(4): 907 - 933. [Abstract] [Full Text] [PDF]